NetApp Inc: 1 director

A director at NetApp Inc sold 8,500 shares at 103.157USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Wood M&A lifts '24e-'26e EPS by 4-6%

Wood M&A lifts '24e-'26e EPS by 4-6%, EBITA up 12-17%. Share now trading at 9.1x '24e EV/EBITA. CEO Sonny Mirborn stepping down in Oct. 24.

Danone : Good start to the year: l-f-l at +4.1% with volume/mix at +1....

>Better-than-expected Q1 both in reported and l-f-l terms - Danone just posted Q1 sales that came in at € 6.789bn (vs VA € 6.695bn), declining by -2.5% with organic sales growth at +4.1% with a good volume/mix effect of +1.2%, pricing at 2.9%, an FX impact of -1.5% and a negative scope effect of -5% (Russia).This is much better than both consensus and ODDO BHF expectations which were at +3.4% l-f-l with a volume/mix of +0.8% and pricing at +2.7%. Net sales ...

Danone : Good start to the year: l-f-l at +4.1% with volume/mix at +1....

>Better-than-expected Q1 both in reported and l-f-l terms - Danone just posted Q1 sales that came in at € 6.789bn (vs VA € 6.695bn), declining by -2.5% with organic sales growth at +4.1% with a good volume/mix effect of +1.2%, pricing at 2.9%, an FX impact of -1.5% and a negative scope effect of -5% (Russia).This is much better than both consensus and ODDO BHF expectations which were at +3.4% l-f-l with a volume/mix of +0.8% and pricing at +2.7%. Net sales ...

Übernahmeangebot von Novartis befürwortet – closing in H1/24 – NDA für...

MOR-Führungsgremien empfehlen Annahme des Übernahmeangebots. Die vorgeschlagene Übernahme durch Novartis sei „im besten Interesse von Morphosys, unseren Aktionärinnen und Aktionären und von Krebspatientinnen und -patienten weltweit", so Morphosys-CEO Jean-Paul Kress am 11.04.24. Die Offerte erfordert eine Mindestannahmeschwelle von 65 %. Die Angebotsfrist soll am 13. 05.24 enden. Mit Erscheinen dieser Publikation stellen wir die Coverage der MorphoSys AG ein.

Optimix Emerging Markets Fund: 1 director

A director at Optimix Emerging Markets Fund sold 5,000 shares at 60.180EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

High Yield Bonds Daily

Okea, PGS

Takeover offer from Novartis approved by MOR Board - closing in H1/24 ...

The proposed takeover by Novartis is "in the best interest of Morphosys, our shareholders and cancer patients worldwide", said Morphosys CEO Jean-Paul Kress on 11.04.24. The offer requires a minimum acceptance threshold of 65%. The offer period is scheduled to end on 13 May 2024. With the release of this publication we will discontinue our coverage of MorphoSys AG.

Benelux Morning Notes

Azelis: Bloomberg report citing M&A interest. BE Semiconductor Industries: 1Q24 preview, focus on order intake. Greenyard: Crème de la Crème acquisition. Just Eat Takeaway.com: Deliveroo reports 1Q24 trading. Melexis: 1Q24 Preview, focus on pricing. NSI: Guidance confirmed, LTV improves, small but interesting investments might come. Sligro: 1Q24 results in line with expectations Vastned: Key €100m single asset disposal achieved

Q1: Good financials, slow ConfIdeS

Q1: solid quarter for Patricia Industries

Nokia : Slightly better results, improving orders

>Q1 2024 results above expectations thanks to Nokia technologies and a better mix in Mobile, improving orders in Networks - Revenues totalled € 4.67bn, down 19% y-o-y at cc below the consensus at € 4.96m. Non-IFRS gross margin was 48.6%, above the consensus at 43.7% thanks to a strong contribution from Nokia Technologies which benefited from significant catch-up net sales in addition to a significant improvements in Mobile Networks partly due to the regional and produ...

Edenred : Q1 2024 beating estimates and reassuring on underlying growt...

>Q1 2024 revenue higher, with organic beat - Edenred has reported total Q1 2024 revenue of € 685m, 3% above forecasts (consensus at € 666m), i.e. a reported increase of 21.4%, of which +20.5% organic, +5.2% from M&A and -4.4% from the forex effect. Organic growth in operating revenues in Q1 was +16.9%, above the consensus at 14.2% (ODDO BHF 13.9%). All the regions are dynamic in organic terms, o/w Europe at +12.8% in Q1 (vs consensus +11.8%), including +7.9% in Fran...

Morning Bulletin - 18 April 2024

The financial sector fixed SOFIX at 805.34 (-0.05%) as Chimimport (CHIM, BGN 0.70, +2.94%), First Investment Bank (FIB, BGN 2.52, +1.61%) and Central Cooperative Bank (CCB, BGN 1.50, +1.35%) offset the negative impact on the main index from Doverie United Holding (DUH, BGN 8.38, -1.18%), Shelly (SLYG, BGN 67.00, -0.30%) and Sopharma (SFA, BGN 6.10, -0.33%). The daily turnover of SOFIX significantly decreased to BGN 0.23m compared to the average one of BGN 0.58m.

SFA Engineering Corp: 1 director

A director at SFA Engineering Corp bought 1,300 shares at 24,350.000KRW and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

Sampath Bank Plc: 1 director

A director at Sampath Bank Plc sold 19,850,000 shares at 80.244LKR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...